▟ Vinebot intrinsic value, daily

← back

CHD Church & Dwight

consumer_staples · valued with opus medium conviction · deep-dived 2026-10-27

HOLD
Intrinsic value$57.33
Price (at call)$105.38
Margin of safety -45.6%
vs market (rating basis) -14.0%

Quality staples compounder, but 34x earnings prices in perfection a 4%-growth business cannot deliver.

The story

Church & Dwight runs a portfolio of niche-leading consumer brands (Arm & Hammer, OxiClean, TheraBreath, Batiste, Hero, Touchland). Its moat is brand strength in categories where it is the number one or two player, plus a lean, asset-light model that grows by buying brands and then gaining distribution. It is a mature, steady compounder: organic growth of 3-4% a year plus bolt-on deals, and it is pruning weaker brands to lift margins.

Reported margins swing because of impairment charges. Underlying margins are about 20%, and recent divestitures plus gross-margin gains justify 21% at steady state. The reported sales-to-capital of 1.0 is weighed down by acquisition goodwill, while capex runs below D&A, so incremental reinvestment of 2.2 is the honest figure. A 10-year horizon fits a durable brand franchise with modest growth. These drivers still value CHD well below the market's roughly 34x earnings, which tells me the price is paying for safety rather than for fundamentals.

Value drivers

Revenue growth (Y1)4.0%
Terminal growth3.0%
Forecast horizon10y
Target operating margin21.0%
Years to target margin5
Sales-to-capital2.20
Beta0.70
Failure probability1.0%
Cost of capital (WACC)7.9%
Terminal WACC9.1%

Valuation bridge

PV of explicit FCFF6.97B
PV of terminal value8.57B
Equity value13.60B
÷ shares → per share$57.33

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 6.45B 4.0% 17.7% 877.07M 112.83M 764.25M 708.42M
2 6.70B 3.9% 18.5% 954.42M 114.08M 840.34M 722.04M
3 6.96B 3.8% 19.3% 1.04B 115.13M 920.21M 732.90M
4 7.21B 3.7% 20.2% 1.12B 115.96M 1.00B 741.11M
5 7.47B 3.6% 21.0% 1.21B 116.57M 1.09B 746.76M
6 7.73B 3.4% 21.0% 1.25B 116.95M 1.13B 718.36M
7 7.98B 3.3% 21.0% 1.29B 117.07M 1.17B 690.29M
8 8.24B 3.2% 21.0% 1.33B 116.94M 1.22B 662.61M
9 8.50B 3.1% 21.0% 1.37B 116.55M 1.26B 635.35M
10 8.75B 3.0% 21.0% 1.42B 115.88M 1.30B 608.55M

Key risks

  • Private-label and promotional pressure squeezes pricing in laundry and litter
  • Acquisition missteps lead to more write-downs (as with Hero, ZICAM and Flawless)
  • Lower volumes as consumers trade down, plus tariff and input-cost inflation

Catalysts

  • Portfolio pruning and Touchland integration lift the mix toward higher-growth, higher-margin brands
  • International expansion of TheraBreath, Hero and Batiste

History

DatePriceIntrinsicMoSRating
2026-10-27$105.38 $57.33 -45.6% HOLD
2026-09-17$95.51 $47.55 -50.2% HOLD
2026-08-10$103.24 $51.07 -50.5% HOLD
2026-06-30$97.90 $49.73 -49.2% HOLD
2026-06-23$96.48 $50.46 -47.7% HOLD